Booster Effectiveness For Kids Against Omicron Drops To 0% At 4 Months Then Goes Negative | Another Study Shows Booster Effectiveness Plunging To 47.3% In Adults | Germany Unmasks, Cases Drop 71%
Did you hear what’s happening? A lot of interesting news broke over the last 24 hours but the following is most important.
As the first headline above reads, a new study revealed Covid mRNA booster effectiveness for kids dropped to 0%, then went negative. Next, for adults, new data explained how booster effectiveness dropped down to 47.3%. Finally, recently released WHO data denoted how after Germany dropped their most recent Covid restrictions, cases almost immediately plummeted by 71%.
Please read the summary of data below but please be sure to check out the sources as well. That said, the information in this post is vital and needs to get out so make sure you share this with friends and family so the truth spreads!
James Cintolo is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
In a new test-negative, case-controlled study of Pfizer Covid vaccine effectiveness against symptomatic Omicron infection in adolescence aged 5-11 & 12-15, 2 dose effectiveness diminished to 28.9% at 2 months in those aged 5-11 & further plummeted to 16.6% at 2 months in those aged 12-15
Next, at 7 months, protection dropped to zero for 12-15 year olds then went negative meaning vaccinated were more likely to suffer symptomatic infection than unvaccinated
Moving on, beginning as early as 2 WEEKS after a booster dose was given to both of the previously mentioned cohorts, vaccine effectiveness was 71.1%. That likely means after 4 WEEKS booster effectiveness would drop to under 35%
2 matched retrospective cohort studies out of Qatar that used data of 2 Mil+ examining Covid mRNA booster effectiveness against symptomatic Omicron infection from Dec 19 2032-Jan 26 2022 revealed only 47.3% (95% CI, 40.7 to 53.3) protection
That being the case it should be said, as most lasting protection against severe disease and death was conferred mainly by prior infection & to a lesser degree dose 1+2, 47.3% effectiveness against only symptomatic disease can no longer justify the harms from boosting (VIT, vascular thrombosis, myopericarditis, cerebral hemorrhage, etc)
RARE ADVERSE EVENTS are defined as ~1 event per 3k-10k & are not rare enough to justify these now ineffective boosters
A new prospective SARS-CoV-2 urine test is here. Essentially, this in-house COVID ELISA test (enzyme-linked immunosorbent assay test) detects anti-nucleocapsid antibodies in the urine which are a tell tale indicator of prior infection. Importantly, the test identified SARS-CoV-2 with 94% sensitivity and 100% specificity
Recently, Germany experienced their highest number of daily COVID case counts since the beginning of the pandemic yet when they lifted most restrictions in April 2022 cases dropped 71% immediately. That said, Covid restrictions have proven utterly useless